Latest News From BioPharmaChem
03 October, 2016
Medical device company; Becton, Dickinson and Company plans to create 20 jobs in Co. Lought. The company which is based in Drogheda produces PosiFlush syringes, used for insulin injection for use by diabetic patients. The site has received €38 million in investment to install to new production lines. The manufacture of one of these lines has already begun.
05 October, 2016
Dublin-based start up will progress its clinical trials to phase three in the near future. This is the final phase before a product is sent out for a trial basis on the market. The product known as Episalvan is an orphan drug designed to treat patients with Epidermolysis Bullosa. An orphan drug is a drug produced to treat rare chronic (meaning the disease is long-lasting) diseases. These diseases affect such a small percentage of the global population that it would not make economic sense to produce them. There are intensives set out by the European medical Agency (EMA) which make it more manageable for companies to produce these drugs. These incentives ensure that drugs that treat these rare illnesses are developed and manufactured. Amryt, Genzyme and Alexion are all producers of Orphan Drugs.
10 October, 2016
More Good news from GE Healthcare, Ringaskiddy, Cork. They have revealed that they intend to construct a GE BioPark in Ringaskiddy. The park will produce ready-made factories and sell them to companies who will soon begin commercial production of new pharmaceuticals. This will in turn speed up the process of getting these new pharmaceuticals to patients in need of them. GE Healthcare will begin recruiting 100 new employees in manufacturing, engineering and quality at the beginning of 2017
12 October, 2016
In the article below a researcher in the medtech sector discusses what drives her through her PhD research. She is completing her PhD in the Tyndall institute, Cork, under the guidance of Dr. Eric Moore. The great thing about this article is that it shows the work that goes on in the background behind the innovations that make Ireland a key player in the medtech industry. Institutions such as the Tyndall, NIBRT and newly opened Cúram help to drive the growth pharma and medtech sectors in Ireland.
14 October, 2016
If you are on the fence about making a move into the pharmaceutical sector in Ireland this article will more than likely persuade you that this sector is the one to be in. With $ 8 million being invested in the biopharma industry in the last decade and 28,200 people employed within the sector this is one of the most affluent sectors within the Irish economy.
17 October, 2016
Last week Amgen scooped up two of the most coveted awards in the Pharma Industry Awards. These awards were: Pharma company of the year and bipharma company of the year. This is no small accomplishment considering that the company was up against pharma giants such as: Pfizer and Bristol, Myers, Squibb. Amgen produce pharmaceuticals for patients that do not have many options left with their treatment. They find ways to treat diseases through a biology first approach. This involves the use of advanced biological diagnostics to shed light onto the root causes of these illnesses.
21 October, 2016
Aerogen a Galway-based company has developed a new and innovative way to treat bronchospasm (a sudden narrowing of the airway). The innovation is to use a vibrating mesh to turn liquid medication into a fine mist. This will be an improvement over the conventional way of delivering respiratory medication which is by using a nebulizer. The new technology will ensure that more of the drug gets to the lungs where it is needed. The company employs around 70 people in Galway. This is a fantastic innovation made possible by the Irish Medical Devices industry. This industry should be bustling over the next decade with the establishment of the Cúram institute in Galway, which opened last month. This institute will bring more and more medical device innovations to Irish soil.
24 October, 2016
Yet another breakthrough for the Irish medical devices industry. Innovation Zed a company which has a research and development in NovaUCD, a research centre for new ventures and entrepreneurs. The research centre is affiliated with University College Dublin. A new product has been produced by Innovation Zed, called Insulcheck. This is a clip-on device which allows a patient with diabetes to monitor their insulin checks on the go. This will have great implications for patient care because healthcare professionals will be able to check how the patient has been taking their medication. This is one of the biggest problems with diabetes care at the moment. Doctors do not know how often patients administer their medication. This small clip-on device will give GPs and Healthcare professionals a way to monitor administration behaviours of the patients giving them the ability to cater the treatment strategy to patients behaviour.
26 October, 2016
Bristol-Myers Squibb is holding a Careers day on the 12th of November in NIBRT. This is a fantastic opportunity for job seekers to network with industry. It is a must for anyone who is looking to get a foothold in the pharmaceutical industry.
27 October, 2016
Bristol-Myers Squibb (BMS) will be on a recruitment drive between now and the end of next year. The company invested $1 bn in the installation of a new manufacturing facility in Cruiserath, Dublin. This is the companies largest investment to date. The main opportunities will be in the following roles:manufacturing, engineering, quality, analytical science, automation and supply chain. By the end of 2017, 230 new employees will be recruited by the company. The roles will be a mix of senior and graduate roles. If you want to find out more about BMS and to network with employees within the company why not attend their careers event in NIBRT on the 12th of November (See the previous post).